Amedeo Caflisch
#124,652
Most Influential Person Now
Researcher
Amedeo Caflisch's AcademicInfluence.com Rankings
Amedeo Caflischmathematics Degrees
Mathematics
#6019
World Rank
#8404
Historical Rank
Applied Mathematics
#187
World Rank
#207
Historical Rank
Measure Theory
#1068
World Rank
#1373
Historical Rank
Download Badge
Mathematics
Amedeo Caflisch's Degrees
- PhD Mathematics University of Zurich
- Masters Mathematics University of Zurich
- Bachelors Mathematics University of Zurich
Similar Degrees You Can Earn
Why Is Amedeo Caflisch Influential?
(Suggest an Edit or Addition)Amedeo Caflisch's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- CHARMM: The biomolecular simulation program (2009) (6525)
- The robustness of pollination networks to the loss of species and interactions: a quantitative approach incorporating pollinator behaviour. (2010) (401)
- Protein structure-based drug design: from docking to molecular dynamics. (2018) (333)
- The protein folding network. (2004) (313)
- Phenylalanine assembly into toxic fibrils suggests amyloid etiology in phenylketonuria. (2012) (307)
- Evaluation of a fast implicit solvent model for molecular dynamics simulations (2002) (280)
- Macrodomain-containing proteins are new mono-ADP-ribosylhydrolases (2013) (277)
- Wordom: a program for efficient analysis of molecular dynamics simulations (2007) (253)
- PARP1 ADP-ribosylates lysine residues of the core histone tails (2010) (250)
- The role of side-chain interactions in the early steps of aggregation: Molecular dynamics simulations of an amyloid-forming peptide from the yeast prion Sup35 (2003) (248)
- Interpreting the aggregation kinetics of amyloid peptides. (2006) (242)
- Wordom: A User-Friendly Program for the Analysis of Molecular Structures, Trajectories, and Free Energy Surfaces (2010) (222)
- Predicting free energy changes using structural ensembles. (2009) (202)
- Prediction of aggregation rate and aggregation‐prone segments in polypeptide sequences (2005) (201)
- FACTS: Fast analytical continuum treatment of solvation (2008) (200)
- Multiple copy simultaneous search and construction of ligands in binding sites: application to inhibitors of HIV-1 aspartic proteinase. (1993) (187)
- Replica exchange molecular dynamics simulations of amyloid peptide aggregation. (2004) (186)
- Efficient Modularity Optimization: Multi-Step Greedy Algorithm and Vertex Mover Refinement (2007) (167)
- Molecular dynamics in drug design. (2015) (157)
- Local modularity measure for network clusterizations. (2005) (156)
- Acid and thermal denaturation of barnase investigated by molecular dynamics simulations. (1995) (154)
- The role of aromaticity, exposed surface, and dipole moment in determining protein aggregation rates (2004) (154)
- Calculation of conformational transitions and barriers in solvated systems: Application to the alanine dipeptide in water (1999) (152)
- Folding simulations of a three-stranded antiparallel β-sheet peptide (2000) (148)
- Exhaustive docking of molecular fragments with electrostatic solvation (1999) (147)
- Complex network analysis of free-energy landscapes (2007) (144)
- Complete Phenotypic Recovery of an Alzheimer's Disease Model by a Quinone-Tryptophan Hybrid Aggregation Inhibitor (2010) (140)
- The Chromodomain of LIKE HETEROCHROMATIN PROTEIN 1 Is Essential for H3K27me3 Binding and Function during Arabidopsis Development (2009) (138)
- Kinase selectivity potential for inhibitors targeting the ATP binding site: a network analysis (2010) (132)
- Molecular dynamics simulation of protein denaturation: solvation of the hydrophobic cores and secondary structure of barnase. (1994) (132)
- Amyloid aggregation on lipid bilayers and its impact on membrane permeability. (2009) (132)
- Thermodynamics and Kinetics of Folding of Two Model Peptides Investigated by Molecular Dynamics Simulations (2000) (131)
- Computational models for the prediction of polypeptide aggregation propensity. (2006) (125)
- Docking small ligands in flexible binding sites (1998) (125)
- Pathways and intermediates of amyloid fibril formation. (2007) (122)
- Designed armadillo repeat proteins as general peptide-binding scaffolds: consensus design and computational optimization of the hydrophobic core. (2008) (120)
- Continuum Electrostatic Energies of Macromolecules in Aqueous Solutions (1997) (119)
- Molecular dynamics simulations of protein folding from the transition state (2002) (116)
- Discovery of a Non-Peptidic Inhibitor of West Nile Virus NS3 Protease by High-Throughput Docking (2009) (114)
- Amyloid fibril polymorphism is under kinetic control. (2010) (110)
- Structure-based drug design identifies polythiophenes as antiprion compounds (2015) (110)
- Structural details of urea binding to barnase: a molecular dynamics analysis. (1999) (104)
- Data publication with the structural biology data grid supports live analysis (2016) (103)
- Quantum mechanical methods for drug design. (2010) (102)
- 9,10‐Anthraquinone hinders β‐aggregation: How does a small molecule interfere with Aβ‐peptide amyloid fibrillation? (2009) (100)
- Replica exchange molecular dynamics simulations of reversible folding (2003) (100)
- Fragment-Based de Novo Ligand Design by Multiobjective Evolutionary Optimization (2008) (99)
- Efficient evaluation of binding free energy using continuum electrostatics solvation. (2004) (98)
- Efficient electrostatic solvation model for protein‐fragment docking (2001) (97)
- α-Helix folding in the presence of structural constraints (2008) (96)
- A Small-Molecule Inhibitor of Lin28. (2016) (92)
- Simulation Studies of Amyloidogenic Polypeptides and Their Aggregates. (2019) (92)
- Kinetic response of a photoperturbed allosteric protein (2013) (92)
- A molecular dynamics approach to the structural characterization of amyloid aggregation. (2006) (91)
- A fluorescence quenching assay to discriminate between specific and nonspecific inhibitors of dengue virus protease. (2009) (89)
- The Free Energy Landscape of Small Molecule Unbinding (2011) (88)
- The folding and dimerization of HIV-1 protease: evidence for a stable monomer from simulations. (2004) (87)
- Proteomic analyses identify ARH3 as a serine mono-ADP-ribosylhydrolase (2017) (87)
- Functional Plasticity in the Substrate Binding Site of β-Secretase (2005) (87)
- Monte Carlo docking of oligopeptides to proteins (1992) (86)
- Specific Inhibition of β-Secretase Processing of the Alzheimer Disease Amyloid Precursor Protein. (2016) (86)
- Structure-based optimization of potent and selective inhibitors of the tyrosine kinase erythropoietin producing human hepatocellular carcinoma receptor B4 (EphB4). (2009) (84)
- Small‐Molecule Inhibitors of METTL3, the Major Human Epitranscriptomic Writer (2020) (83)
- Discovery of ZAP70 inhibitors by high-throughput docking into a conformation of its kinase domain generated by molecular dynamics. (2013) (83)
- Kinetic analysis of molecular dynamics simulations reveals changes in the denatured state and switch of folding pathways upon single‐point mutation of a β‐sheet miniprotein (2008) (83)
- Specificity and mechanism-of-action of the JAK2 tyrosine kinase inhibitors ruxolitinib and SAR302503 (TG101348) (2014) (82)
- Proteostasis of Islet Amyloid Polypeptide: A Molecular Perspective of Risk Factors and Protective Strategies for Type II Diabetes. (2021) (82)
- In Silico Discovery of β-Secretase Inhibitors (2006) (77)
- Dynamic microfluidic control of supramolecular peptide self-assembly (2016) (76)
- One-dimensional barrier-preserving free-energy projections of a beta-sheet miniprotein: new insights into the folding process. (2008) (76)
- Automatic and efficient decomposition of two-dimensional structures of small molecules for fragment-based high-throughput docking. (2006) (76)
- Epigenetic mechanisms regulate stage differentiation in the minimized protozoan Giardia lamblia (2010) (76)
- Discovery of cell-permeable non-peptide inhibitors of beta-secretase by high-throughput docking and continuum electrostatics calculations. (2005) (76)
- Characterization and further stabilization of designed ankyrin repeat proteins by combining molecular dynamics simulations and experiments. (2008) (74)
- Micelle-like architecture of the monomer ensemble of Alzheimer's amyloid-β peptide in aqueous solution and its implications for Aβ aggregation. (2010) (73)
- Flaviviral protease inhibitors identified by fragment-based library docking into a structure generated by molecular dynamics. (2009) (72)
- Enhancer RNA m6A methylation facilitates transcriptional condensate formation and gene activation. (2021) (71)
- Computer simulations of protein folding by targeted molecular dynamics (2000) (71)
- Carnosine Inhibits Aβ42 Aggregation by Perturbing the H‐Bond Network in and around the Central Hydrophobic Cluster (2013) (70)
- A novel allosteric mechanism in the cysteine peptidase cathepsin K discovered by computational methods (2014) (70)
- Network and graph analyses of folding free energy surfaces. (2006) (68)
- Discovery of CREBBP Bromodomain Inhibitors by High-Throughput Docking and Hit Optimization Guided by Molecular Dynamics. (2016) (67)
- Automated docking of highly flexible ligands by genetic algorithms: A critical assessment (2004) (66)
- Fragment-Based Flexible Ligand Docking by Evolutionary Optimization (2001) (66)
- Structure‐based tailoring of compound libraries for high‐throughput screening: Discovery of novel EphB4 kinase inhibitors (2008) (65)
- Multistep greedy algorithm identifies community structure in real-world and computer-generated networks (2008) (65)
- Phi-value analysis by molecular dynamics simulations of reversible folding. (2005) (64)
- Membrane localization and flexibility of a lipidated ras peptide studied by molecular dynamics simulations. (2004) (63)
- Weak temperature dependence of the free energy surface and folding pathways of structured peptides (2002) (63)
- Role of native topology investigated by multiple unfolding simulations of four SH3 domains. (2001) (61)
- Discovery of BRD4 bromodomain inhibitors by fragment-based high-throughput docking. (2014) (60)
- Flexibility of the murine prion protein and its Asp178Asn mutant investigated by molecular dynamics simulations. (2001) (59)
- Computational combinatorial ligand design: Application to human α-thrombin (1996) (57)
- Free Energy Surface of the Helical Peptide Y(MEARA)6 (2000) (57)
- Native topology or specific interactions: what is more important for protein folding? (2001) (57)
- Discovery of Plasmepsin Inhibitors by Fragment‐Based Docking and Consensus Scoring (2009) (56)
- Discovery of kinase inhibitors by high-throughput docking and scoring based on a transferable linear interaction energy model. (2008) (54)
- Dynamic 3D proteomes reveal protein functional alterations at high resolution in situ (2020) (53)
- Targeted Molecular Dynamics Simulations of Protein Unfolding (2000) (52)
- Computational combinatorial chemistry for de novo ligand design: Review and assessment (1995) (50)
- Fragment-Based Design of Selective Nanomolar Ligands of the CREBBP Bromodomain. (2016) (50)
- Calculation of protein ionization equilibria with conformational sampling: pKa of a model leucine zipper, GCN4 and barnase (2002) (48)
- Is quantum mechanics necessary for predicting binding free energy? (2008) (48)
- Folding simulations of a three-stranded antiparallel beta -sheet peptide. (2000) (48)
- Crowding Effects on Amyloid Aggregation Kinetics (2010) (47)
- Spontaneous formation of detergent micelles around the outer membrane protein OmpX. (2005) (47)
- Comparison of a GB Solvation Model with Explicit Solvent Simulations: Potentials of Mean Force and Conformational Preferences of Alanine Dipeptide and 1,2-Dichloroethane (1998) (47)
- Disordered Binding of Small Molecules to Aβ(12–28)* (2011) (46)
- Predicting free energy changes using structural ensembles (2009) (45)
- Structured Water Molecules in the Binding Site of Bromodomains Can Be Displaced by Cosolvent (2014) (45)
- Flexibility of monomeric and dimeric HIV-1 protease (2003) (44)
- Efficient Construction of Mesostate Networks from Molecular Dynamics Trajectories. (2012) (44)
- Specificity and mechanism-of-action of the JAK2 tyrosine kinase inhibitors ruxolitinib and SAR302503 (TG101348) (2014) (43)
- Library screening by fragment‐based docking (2009) (42)
- Forces and energetics of hapten-antibody dissociation: a biased molecular dynamics simulation study. (2001) (42)
- Hydrophobicity at the surface of proteins (1999) (42)
- Analysis of the distributed computing approach applied to the folding of a small β peptide (2003) (41)
- Docking by Monte Carlo minimization with a solvation correction: Application to an FKBP—substrate complex (1997) (41)
- A double‐headed cathepsin B inhibitor devoid of warhead (2008) (41)
- 2D-IR study of a photoswitchable isotope-labeled alpha-helix. (2010) (40)
- Computational ligand design. (1999) (39)
- Distribution of Reciprocal of Interatomic Distances: A Fast Structural Metric. (2012) (39)
- Delineation of folding pathways of a β-sheet miniprotein. (2011) (39)
- Ser170 controls the conformational multiplicity of the loop 166–175 in prion proteins: implication for conversion and species barrier (2007) (39)
- Discovery of a novel chemotype of tyrosine kinase inhibitors by fragment-based docking and molecular dynamics. (2012) (38)
- Estimation of protein folding probability from equilibrium simulations. (2005) (38)
- Discovery of Tyrosine Kinase Inhibitors by Docking into an Inactive Kinase Conformation Generated by Molecular Dynamics (2012) (37)
- Does bromodomain flexibility influence histone recognition? (2013) (36)
- Fast protein folding on downhill energy landscape (2003) (36)
- Organism complexity anti‐correlates with proteomic β‐aggregation propensity (2005) (35)
- Optimization of designed armadillo repeat proteins by molecular dynamics simulations and NMR spectroscopy (2012) (35)
- ALMOST: An all atom molecular simulation toolkit for protein structure determination (2014) (35)
- NMR study of complexes between low molecular mass inhibitors and the West Nile virus NS2B–NS3 protease (2009) (35)
- Identification of the protein folding transition state from molecular dynamics trajectories. (2009) (34)
- High‐Throughput Virtual Screening Using Quantum Mechanical Probes: Discovery of Selective Kinase Inhibitors (2010) (34)
- A Gain-of-Function Mutation of Arabidopsis CRYPTOCHROME1 Promotes Flowering1[W][OA] (2010) (34)
- Factor XIII activation peptide is released into plasma upon cleavage by thrombin and shows a different structure compared to its bound form (2007) (34)
- Concurrent Cooperativity and Substrate Inhibition in the Epoxidation of Carbamazepine by Cytochrome P450 3A4 Active Site Mutants Inspired by Molecular Dynamics Simulations (2014) (34)
- The "Gatekeeper" Residue Influences the Mode of Binding of Acetyl Indoles to Bromodomains. (2016) (33)
- Peptide Binding to a PDZ Domain by Electrostatic Steering via Nonnative Salt Bridges. (2015) (33)
- The protonation state of the catalytic aspartates in plasmepsin II (2007) (33)
- High-Throughput Fragment Docking into the BAZ2B Bromodomain: Efficient in Silico Screening for X-Ray Crystallography. (2016) (32)
- Structural basis for inhibiting β-amyloid oligomerization by a non-coded β-breaker-substituted endomorphin analogue. (2011) (32)
- Evolutionary conserved Tyr169 stabilizes the β2-α2 loop of the prion protein. (2015) (31)
- Small Molecule Binding to Proteins: Affinity and Binding/Unbinding Dynamics from Atomistic Simulations (2011) (31)
- Functional plasticity in the substrate binding site of beta-secretase. (2005) (30)
- A molecular simulation protocol to avoid sampling redundancy and discover new states. (2015) (29)
- Twenty Crystal Structures of Bromodomain and PHD Finger Containing Protein 1 (BRPF1)/Ligand Complexes Reveal Conserved Binding Motifs and Rare Interactions. (2016) (29)
- Free energy surfaces from single-distance information. (2010) (28)
- Fragment-Based de Novo Ligand Design by Multiobjective Evolutionary Optimization. (2008) (28)
- Amyloid β Fibril Elongation by Monomers Involves Disorder at the Tip. (2017) (28)
- Formation of the folding nucleus of an SH3 domain investigated by loosely coupled molecular dynamics simulations. (2004) (27)
- New insights into the folding of a β-sheet miniprotein in a reduced space of collective hydrogen bond variables: application to a hydrodynamic analysis of the folding flow. (2013) (27)
- Three stories on Eph kinase inhibitors: From in silico discovery to in vivo validation. (2016) (26)
- Mechanism and Kinetics of Acetyl-Lysine Binding to Bromodomains. (2013) (26)
- Binding Mode of Acetylated Histones to Bromodomains: Variations on a Common Motif (2015) (26)
- Computational analysis of the S. cerevisiae proteome reveals the function and cellular localization of the least and most amyloidogenic proteins (2007) (26)
- Structure‐based ligand design by a build‐up approach and genetic algorithm search in conformational space (2001) (26)
- Optimization of inhibitors of the tyrosine kinase EphB4. 2. Cellular potency improvement and binding mode validation by X-ray crystallography. (2013) (25)
- A scalable algorithm to order and annotate continuous observations reveals the metastable states visited by dynamical systems (2013) (25)
- Pyrrolo[3,2-b]quinoxaline derivatives as types I1/2 and II Eph tyrosine kinase inhibitors: structure-based design, synthesis, and in vivo validation. (2014) (25)
- Structural and Dynamic Insights into Redundant Function of YTHDF Proteins (2020) (25)
- Monte carlo minimization with thermalization for global optimization of polypeptide conformations in cartesian coordinate space (1992) (25)
- Discovery of dual ZAP70 and Syk kinases inhibitors by docking into a rare C-helix-out conformation of Syk. (2014) (24)
- Molecular Dynamics Studies of Protein and Peptide Folding and Unfolding (1994) (24)
- Surfactant effects on amyloid aggregation kinetics. (2011) (24)
- Derivatives of 3-Amino-2-methylpyridine as BAZ2B Bromodomain Ligands: In Silico Discovery and in Crystallo Validation. (2016) (23)
- ETNA: equilibrium transitions network and Arrhenius equation for extracting folding kinetics from REMD simulations. (2009) (23)
- Discovery of Inhibitors of Four Bromodomains by Fragment-Anchored Ligand Docking. (2017) (23)
- The ATAD2 bromodomain binds different acetylation marks on the histone H4 in similar fuzzy complexes (2017) (23)
- In silico discovery of beta-secretase inhibitors. (2006) (22)
- Free Energy Guided Sampling. (2012) (22)
- How does a simplified-sequence protein fold? (2009) (22)
- Design of dimerization inhibitors of HIV-1 aspartic proteinase: A computer-based combinatorial approach (2000) (21)
- On the orientation of the catalytic dyad in aspartic proteases (2010) (21)
- Chemical Space Expansion of Bromodomain Ligands Guided by in Silico Virtual Couplings (AutoCouple) (2018) (21)
- Virtual screen to NMR (VS2NMR): Discovery of fragment hits for the CBP bromodomain. (2017) (20)
- Dynamics in the active site of β-secretase: a network analysis of atomistic simulations. (2011) (20)
- Fragment-Based Docking: Development of the CHARMMing Web User Interface as a Platform for Computer-Aided Drug Design (2014) (20)
- Activation of the West Nile virus NS3 protease: Molecular dynamics evidence for a conformational selection mechanism (2009) (20)
- 1,4,9-Triazaspiro[5.5]undecan-2-one Derivatives as Potent and Selective METTL3 Inhibitors. (2021) (20)
- Experimental and computational study of BODIPY dye-labeled cavitand dynamics. (2014) (20)
- Discovery of BAZ2A bromodomain ligands. (2017) (20)
- Extracting physically intuitive reaction coordinates from transition networks of a beta-sheet miniprotein. (2010) (20)
- Current kinase inhibitors cover a tiny fraction of fragment space. (2015) (19)
- Equilibrium distribution from distributed computing (simulations of protein folding). (2011) (19)
- Change of the unbinding mechanism upon a mutation: A molecular dynamics study of an antibody–hapten complex (2005) (18)
- Pepsinogen‐like activation intermediate of plasmepsin II revealed by molecular dynamics analysis (2008) (18)
- Soluble Protofibrils as Metastable Intermediates in Simulations of Amyloid Fibril Degradation Induced by Lipid Vesicles (2010) (18)
- Structure-based discovery of selective BRPF1 bromodomain inhibitors. (2018) (18)
- How Does Darunavir Prevent HIV-1 Protease Dimerization? (2012) (18)
- 50 Years of Lifson-Roig Models: Application to Molecular Simulation Data. (2012) (18)
- Spontaneous self-assembly of engineered armadillo repeat protein fragments into a folded structure. (2014) (17)
- A Reader-Based Assay for m6A Writers and Erasers. (2019) (17)
- Molecular Dynamics Simulations of Bromodomains Reveal Binding‐Site Flexibility and Multiple Binding Modes of the Natural Ligand Acetyl‐Lysine (2014) (17)
- Computationally Designed Armadillo Repeat Proteins for Modular Peptide Recognition. (2016) (17)
- The role of flexibility and hydration on the sequence‐specific DNA recognition by the Tn916 integrase protein: a molecular dynamics analysis (2004) (17)
- Organism complexity anti-correlates with proteomic beta-aggregation propensity. (2005) (16)
- Docking by Monte Carlo minimization with a solvation correction: Application to an FKBP - substrate complex (1997) (16)
- N,N Dimethylacetamide a drug excipient that acts as bromodomain ligand for osteoporosis treatment (2017) (16)
- Unfolding transition state and intermediates of the tumor suppressor p16INK4a investigated by molecular dynamics simulations (2006) (15)
- High-Resolution Visualisation of the States and Pathways Sampled in Molecular Dynamics Simulations (2014) (15)
- Comment on the validation of continuum electrostatics models (1999) (15)
- Disorder at the Tips of a Disease-Relevant Aβ42 Amyloid Fibril: A Molecular Dynamics Study. (2018) (15)
- Slow folding of cross-linked alpha-helical peptides due to steric hindrance. (2010) (15)
- Peptide binding to the PDZ3 domain by conformational selection (2012) (15)
- Photocontrol of reversible amyloid formation with a minimal-design peptide. (2012) (15)
- Sequential unfolding of individual helices of bacterioopsin observed in molecular dynamics simulations of extraction from the purple membrane. (2006) (14)
- An evolutionary approach for structure-based design of natural and non-natural peptidic ligands. (2001) (14)
- Methylations of tryptophan-modified naphthoquinone affect its inhibitory potential toward Aβ aggregation. (2013) (14)
- Atomistic and Thermodynamic Analysis of N6-Methyladenosine (m6A) Recognition by the Reader Domain of YTHDC1. (2021) (14)
- Folding for binding or binding for folding? (2003) (13)
- In silico fragment-based drug design with SEED. (2018) (13)
- Data Management System for Distributed Virtual Screening (2009) (13)
- Combining task- and data parallelism to speed up protein folding on a desktop grid platform (2003) (13)
- Serotonin uptake is required for Rac1 activation in Kras‐induced acinar‐to‐ductal metaplasia in the pancreas (2018) (13)
- Flexible binding of m6A reader protein YTHDC1 to its preferred RNA motif. (2019) (12)
- Molecular Dynamics Simulations to Study Protein Folding and Unfolding (2008) (12)
- Fragment-based in silico screening of bromodomain ligands. (2016) (12)
- Solution conformation of phakellistatin 8 investigated by molecular dynamics simulations. (1999) (12)
- Inhibition of interdomain motion in g‐actin by the natural product latrunculin: A molecular dynamics study (2012) (12)
- Complementing ultrafast shape recognition with an optical isomerism descriptor. (2010) (12)
- Performance characterization of a molecular dynamics code on PC clusters: is there any easy parallelism in CHARMM? (2002) (11)
- Weighted Distance Functions Improve Analysis of High-Dimensional Data: Application to Molecular Dynamics Simulations. (2015) (10)
- In silico identification and crystal structure validation of caspase-3 inhibitors without a P1 aspartic acid moiety. (2011) (10)
- Bulky side chains and non-native salt bridges slow down the folding of a cross-linked helical peptide: a combined molecular dynamics and time-resolved infrared spectroscopy study. (2009) (10)
- Mechanisms and Kinetics of Amyloid Aggregation Investigated by a Phenomenological Coarse-Grained Model (2012) (10)
- Structural Analysis of the Binding of Type I, I1/2, and II Inhibitors to Eph Tyrosine Kinases. (2015) (10)
- Equilibrium sampling approach to the interpretation of electron density maps. (2014) (10)
- Protein dynamics: From the native to the unfolded state and back again (1995) (10)
- Selectively disrupting m6A-dependent protein-RNA interactions with fragments. (2020) (9)
- Computer-Aided Design of Thrombin Inhibitors. (1998) (9)
- A sphere-based model for the electrostatics of globular proteins. (2003) (9)
- Flexible binding of m6A reader protein YTHDC1 to its preferred RNA motif (2019) (9)
- On the removal of initial state bias from simulation data. (2019) (9)
- Structural Analysis of Small‐Molecule Binding to the BAZ2A and BAZ2B Bromodomains (2018) (9)
- Disulfide bridge formation influences ligand recognition by the ATAD2 bromodomain (2018) (9)
- In Silico Identification of JMJD3 Demethylase Inhibitors (2018) (9)
- Fast Analytical Continuum Treatments of Solvation (2010) (9)
- Thermostable designed ankyrin repeat proteins (DARPins) as building blocks for innovative drugs (2021) (9)
- Flanking sequence preference modulates de novo DNA methylation in the mouse genome (2020) (9)
- Efficient evaluation of the effective dielectric function of a macromolecule in aqueous solution (2003) (8)
- Silybins inhibit human IAPP amyloid growth and toxicity through stereospecific interactions. (2022) (7)
- The roles of the conserved tyrosine in the β2-α2 loop of the prion protein (2015) (7)
- Automatic and efficient decomposition of 2D-structures of small molecules for fragment-based high-throughput docking (2006) (7)
- SAPPHIRE-based clustering. (2020) (7)
- A combined NMR and computational approach to investigate peptide binding to a designed Armadillo repeat protein. (2015) (7)
- A small-molecule inhibitor of Lin 28 (2016) (7)
- Focused conformational sampling in proteins. (2017) (7)
- Assessment of the Fragment Docking Program SEED (2020) (6)
- Estimation of folding probabilities and phi values from molecular dynamics simulations of reversible Peptide folding. (2007) (6)
- The role of the N-terminal amphipathic helix (N-AH) in bacterial YidC: Insights from functional studies, the crystal structure and molecular dynamics simulations. (2021) (5)
- Discovery of BAZ 2 A bromodomain ligands (2017) (5)
- Binding Motifs in the CBP Bromodomain: An Analysis of 20 Crystal Structures of Complexes with Small Molecules. (2018) (5)
- Wild type and mutants of the HET‐s(218–289) prion show different flexibility at fibrillar ends: A simulation study (2014) (5)
- Hitting a Moving Target: Simulation and Crystallography Study of ATAD2 Bromodomain Blockers. (2020) (5)
- One-Dimensional Barrier Preserving Free-Energy Projections of a β-sheet Miniprotein : New Insights into the Folding Process SUPPLEMENTARY MATERIAL (2007) (5)
- Protein Structural Memory Influences Ligand Binding Mode(s) and Unbinding Rates. (2016) (5)
- An ABSINTH-Based Protocol for Predicting Binding Affinities between Proteins and Small Molecules (2020) (5)
- A Gain-of-Function Mutation of Arabidopsis CRYPTOCHROME1 Promotes Flowering 1[W][OA] (2010) (5)
- Synthesis, radiolabelling and initial biological characterisation of 18F-labelled xanthine derivatives for PET imaging of Eph receptors. (2020) (4)
- Protein folding: simple models for a complex process. (2004) (4)
- Free Energy Guided Sampling. (2012) (4)
- Iriomoteolides: novel chemical tools to study actin dynamics (2018) (4)
- Reducing the Flexibility of Type II Dehydroquinase for Inhibition: A Fragment‐Based Approach and Molecular Dynamics Study (2017) (4)
- Structure-based design of ligands of the m6A-RNA reader YTHDC1 (2022) (3)
- Hydrophobicity maps and docking of molecular fragments with solvation (2000) (3)
- Dynamics of the Histone Acetyltransferase Lysine-Rich Loop in the Catalytic Core of the CREB-Binding Protein (2022) (3)
- Structure-Based Combinatorial Ligand Design (2018) (3)
- S-1 Supplementary Information Discovery of cell-permeable nonpeptide inhibitors of β-secretase by high-throughput docking and continuum electrostatics calculations (3)
- Specific Inhibition of b-Se cretase Processing of the Alzheimer Disease Amyloid Precursor Protein (2016) (3)
- Kinetic Control of Amyloidogenesis Calls for Unconventional Drugs To Fight Alzheimer's Disease. (2020) (3)
- Combined computational and cellular screening identifies synergistic inhibition of SARS-CoV-2 by lenvatinib and remdesivir (2021) (3)
- Fragment‐Based Approaches in Virtual Screening (2011) (3)
- 1 Identification of lead-like and non-lead-like inhibitors for dengue virus NS 2 B / NS 3 protease by tryptophan fluorescence (2009) (3)
- The combined force field-sampling problem in simulations of disordered amyloid-β peptides (2019) (3)
- Unsupervised identification of states from voltage recordings of neural networks (2019) (3)
- Complexity in Protein Folding : Simulation Meets Experiment (2011) (3)
- Validation of network clusterizations (2005) (2)
- Domino effect in allosteric signaling of peptide binding. (2022) (2)
- Specific Inhibition of bSe cretase Processing of the Alzheimer Disease Amyloid Precursor Protein Graphical (2016) (2)
- Ligand retargeting by binding site analogy. (2019) (2)
- Ultrametricity in Protein Folding Dynamics. (2012) (2)
- Complexity in Protein Folding: Simulation Meets Experiment (2012) (2)
- Antibody binding modulates the dynamics of the membrane bound prion protein. (2022) (1)
- 1 2 DIR study of a photo-switchable isotope-labeled α-helix (2010) (1)
- Fragment Ligands of the m6A-RNA Reader YTHDF2 (2022) (1)
- Ginkgolic acids inhibit SARS-CoV-2 and its variants by blocking the spike protein/ACE2 interplay (2022) (1)
- Identification of a BAZ2A Bromodomain Hit Compound by Fragment Joining (2021) (1)
- Interactions of curcumin’s degradation products with the Aβ42 dimer: A computational study (2022) (1)
- Understanding the mechanism of action of pyrrolo[3,2-b]quinoxaline-derivatives as kinase inhibitors† †Electronic supplementary information (ESI) available: General procedures for the synthesis, characterization and biological evaluation of all reported compounds can be found in the ESI. See DOI: 10. (2020) (1)
- The slow folding of cross-linked α-helical peptides is due to steric hindrance SUPPLEMENTARY MATERIAL (2009) (1)
- Correction to Concurrent Cooperativity and Substrate Inhibition in the Epoxidation of Carbamazepine by Cytochrome P450 3A4 Active Site Mutants Inspired by Molecular Dynamics Simulations (2016) (1)
- Antibody binding increases the flexibility of the prion protein. (2022) (1)
- Rapid ex vivo reverse genetics identifies the essential determinants of prion protein toxicity (2022) (1)
- The role of the N-terminal amphipathic helix in bacterial YidC: Insights from functional studies, the crystal structure and molecular dynamics simulations (2021) (1)
- Molecular dynamics analysis of the structural properties of the transglutaminases of Kutzneria albida and Streptomyces mobaraensis (2022) (1)
- Fragment-based de novo ligand design by multi-objective evolutionary optimization. Supporting Information (2008) (1)
- A Gain-of-Function Mutation of Arabidopsis CRYPTOCHROME 1 Promotes Flowering 1 [ W ] [ OA ] (2010) (1)
- Slow Folding of Cross-Linked r-Helical Peptides Due to Steric Hindrance (2010) (1)
- X-Ray Diffraction data from BAZ2B bromodomain in complex with acetylindole compound UZH50, source of 5E74 structure (2016) (0)
- Crystal structure of YTHDC1 with fragment 22 (ACA_DC1_001) (2020) (0)
- Crystal structure of the bromodomain of human CREBBP in complex with XZ08 (2015) (0)
- The ATAD2 bromodomain in complex with compound 13 (2019) (0)
- The ATAD2 bromodomain in complex with compound 6 (2018) (0)
- Crystal structure of the human METTL3-METTL14 complex with compound UOZ094 (2021) (0)
- Crystal structure of YTHDC1 M438A mutant (2021) (0)
- Crystal structure of YTHDC1 with compound DHU_DC1_180 (2020) (0)
- Crystal structure of human BRD4(1) bromodomain in complex with UT22B (2018) (0)
- Crystal structure of hMTH1 N33A in complex with LW14 in the absence of acetate (2019) (0)
- Crystal structure of the human METTL3-METTL14 complex bound to Compound 4 (ASI_M3M_047) (2020) (0)
- Crystal structure of hMTH1 N33G in complex with LW14 in the presence of acetate (2019) (0)
- M. A. Menzies & C. J. Hawkesworth 1987. Mantle Metasomatism. xix + 472 pp. London, Orlando, San Diego, New York, Austin, Boston, Sydney, Tokyo, Toronto: Academic Press. Price £46.00, $76.00 (hard covers). ISBN 0 12 491080 7. (1988) (0)
- Supporting Information for Discovery of BAZ2A Bromodomain Ligands (2022) (0)
- Crystal structure of the human METTL3-METTL14 complex with compound UOZ040a (2021) (0)
- Crystal structure of YTHDC1 with fragment 17 (DHU_DC1_042) (2020) (0)
- Crystal structure of the human METTL3-METTL14 complex with compound UOZ019a (2021) (0)
- S-1 Supporting Information Flaviviral protease inhibitors identied by fragment-based library docking into a structure generated by molecular dynamics (2009) (0)
- Crystal structure of the human METTL3-METTL14 complex with compound UOZ083 (2021) (0)
- Crystal structure of the human BRPF1 bromodomain in complex with SEED7 (2016) (0)
- Crystal structure of YTHDC1 with fragment 28 (DHU_DC1_176) (2020) (0)
- The ATAD2 bromodomain in complex with compound 5 (2018) (0)
- Crystal structure of hMTH1 N33A in the presence of acetate (2019) (0)
- Crystal structure of hMTH1 N33A in complex with LW14 in the presence of acetate (2019) (0)
- MTH1 in complex with fragment 1 (2018) (0)
- Crystal Structure of BAZ2B bromodomain in complex with fragment F39 (2016) (0)
- The ATAD2 bromodomain in complex with compound 3 (2018) (0)
- Crystal structure of the bromodomain of human ATAD2 in complex with Compound A12 (2016) (0)
- Crystal structure of CREBBP bromodomain complexd with PB08 (2018) (0)
- Manual for GANDI Genetic Algorithm-based de Novo Design of Inhibitors Version 2 . 0 (2008) (0)
- Crystal structure of hMTH1 N33A in complex with TH scaffold 1 in the absence of acetate (2019) (0)
- Editorial overview: Folding and binding: In silico, in vitro and in cellula. (2018) (0)
- Crystal structure of CREBBP bromodomain complexd with PA10 (2018) (0)
- Crystal structure of CREBBP bromodomain complexed with LB32A (2020) (0)
- Crystal Structure of the first bromodomain of BRD4 in complex with AYC (2014) (0)
- Human EphA3 Kinase domain in complex with ligand 90 (2013) (0)
- Molecular graphics for protein folding simulations (1991) (0)
- Crystal Structure of BAZ2B bromodomain in complex with fragment F103 (2016) (0)
- Hydrophobicity and functionality maps of farnesyltransferase. (2001) (0)
- Crystal structure of the bromodomain of human CREBBP in complex with UP39 (2016) (0)
- Crystal structure of the human BRPF1 bromodomain in complex with SEED10 (2016) (0)
- The ATAD2 bromodomain in complex with compound 10 (2019) (0)
- Crystal Structure of BAZ2A bromodomain in complex with acetylindole compound UZH47 (2015) (0)
- Crystal Structure of BAZ2B bromodomain in complex with 4-chloropyridine derivative 3 (2017) (0)
- Crystal structure of the human METTL3-METTL14 complex with compound UOZ111 (2021) (0)
- Crystal structure of the human METTL3-METTL14 complex bound to Compound 19 (ADO_AE_009) (2021) (0)
- Crystal structure of YTHDC1 with fragment 26 (DHU_DC1_198) (2020) (0)
- Crystal structure of the human METTL3-METTL14 complex bound to Compound 1/Adenosine (DHU_M3M_023) (2020) (0)
- Crystal structure of YTHDC1 with compound PSI_DC1_002 (2021) (0)
- Crystal structure of the bromodomain of human CREBBP in complex with UN32 (2016) (0)
- Crystal structure of YTHDC1 with fragment 20 (DHU_DC1_134) (2020) (0)
- Amyloid fibril polymorphism is under kinetic control Supplementary Information (2010) (0)
- Crystal Structure of SMARCA4 bromodomain in complex with MPD (2016) (0)
- The ATAD2 bromodomain in complex with compound 4 (2019) (0)
- Crystal structure of YTHDC1 with compound DHU_DC1_135 (2020) (0)
- Crystal structure of YTHDC1 with compound DHU_DC1_078 (2020) (0)
- Crystal Structure of BAZ2A bromodomain in complex with acetophenone derivative 4 (2017) (0)
- Crystal structure of the human BRPF1 bromodomain in complex with DSPBP1010 (2018) (0)
- Crystal structure of YTHDC1 apo purified using GST tag (2020) (0)
- Crystal structure of YTHDC1 with fragment 24 (PSI_DC1_003) (2020) (0)
- Crystal structure of YTHDC1 with compound DHU_DC1_038 (2020) (0)
- Crystal structure of the human METTL3-METTL14 complex with compound UOZ040b (2021) (0)
- The ATAD2 bromodomain in complex with compound 9 (2019) (0)
- The ATAD2 bromodomain in complex with compound 14 (2019) (0)
- Crystal structure of human METTL1 bound to Sinefungin (2021) (0)
- Crystal structure of the human METTL3-METTL14 complex with compound UOZ090 (2021) (0)
- Crystal structure of hMTH1 N33G in the presence of acetate (2019) (0)
- Crystal structure of the human BRPF1 bromodomain in complex with SEED15 (2016) (0)
- Crystal structure of YTHDC1 with fragment 5 (DHU_DC1_066) (2020) (0)
- Crystal structure of the human BRPF1 bromodomain in complex with DSPBP1004 (2018) (0)
- Three Stories on Eph Kinase Inhibitors: From in silico Discovery to in vivo Validation (2016) (0)
- Crystal Structure of BAZ2B bromodomain in complex with 1-methylpyridinone compound 1 (2018) (0)
- Crystal structure of the human METTL3-METTL14 complex with compound UOZ059b (2021) (0)
- Crystal structure of YTHDC1 with fragment 30 (DHU_DC1_220) (2020) (0)
- Author ' s personal copy Discovery of ZAP 70 inhibitors by high-throughput docking into a conformation of its kinase domain generated by molecular dynamics (2013) (0)
- Crystal structure of the human BRPF1 bromodomain in complex with BZ061 (2018) (0)
- Crystal structure of YTHDC1 with fragment 19 (DHU_DC1_045) (2020) (0)
- Crystal structure of the human BRPF1 bromodomain in complex with BZ047 (2018) (0)
- Crystal structure of the bromodomain of human CREBBP in complex with ACA007 (2020) (0)
- Crystal structure of the human BRPF1 bromodomain in complex with SEED21 (2016) (0)
- Crystal structure of YTHDC1 S378A mutant (2021) (0)
- MTH1 in complex with fragment 9 (2018) (0)
- Human EphA3 Kinase domain in complex with ligand 66 (2013) (0)
- Crystal structure of the human METTL3-METTL14 complex bound to Compound 22 (UZH2) (2021) (0)
- MTH1 in complex with fragment 6 (2018) (0)
- Crystal structure of YTHDC1 with fragment 2 (DHU_DC1_140) (2020) (0)
- The ATAD2 bromodomain in complex with compound UZH-DQ41 (2018) (0)
- Crystal structure of YTHDC1 with compound DHU_DC1_222 (2021) (0)
- Crystal structure of human BRD4(1) bromodomain in complex with JRMBR4106 (2018) (0)
- Crystal structure of CREBBP bromodomain complexed with DSPB2A002 (2018) (0)
- Crystal structure of CREBBP bromodomain complexd with DR46 (2019) (0)
- Crystal structure of the human METTL3-METTL14 complex bound to Compound 8 (ASI_M3M_091) (2020) (0)
- Human EphA3 Kinase domain in complex with Birb796 (2015) (0)
- MTH1 in complex with fragment 8 (2018) (0)
- Crystal Structure of BAZ2B bromodomain in complex with 1-methylpyridinone compound 3 (2018) (0)
- Supporting Information Atomistic and thermodynamic analysis of the N6-methyladenosine (m6A) recognition by the reader domain of YTHDC1 (2020) (0)
- Flexibility of Type II Dehydroquinase for Inhibition: A Fragment-Based Approach and Molecular Dynamics (2018) (0)
- The YTH domain of YTHDC1 protein in complex with m6ACU oligonucleotide (2019) (0)
- Crystal structure of the human BRPF1 bromodomain in complex with SEED19 (2016) (0)
- Crystal Structure of BAZ2A bromodomain in complex with 1-methylpyridinone compound 5 (2018) (0)
- Crystal structure of the human METTL3-METTL14 complex with compound UOZ059a (2021) (0)
- Crystal structure of YTHDF2 in complex with m1A (2021) (0)
- Crystal structure of YTHDC1 with compound T96C1 (2020) (0)
- The ATAD2 bromodomain in complex with compound UZH-DS15 (2018) (0)
- Crystal structure of YTHDC1 S378A mutant complex with m6A (2021) (0)
- Crystal structure of the human METTL3-METTL14 complex with compound UOZ078 (2021) (0)
- Crystal structure of CREBBP bromodomain complexd with DT29 (2018) (0)
- Crystal structure of the human METTL3-METTL14 complex bound to Compound 2 (ASI_M3M_140) (2020) (0)
- Crystal Structure of BAZ2A bromodomain in complex with 1-methylpyridine derivative 1 (2017) (0)
- Crystal structure of hMTH1 D120N in the presence of acetate (2019) (0)
- Crystal structure of YTHDC1 with fragment 13 (DHU_DC1_153) (2020) (0)
- Crystal structure of YTHDC1 with compound DHU_DC1_232 (2021) (0)
- Crystal structure of YTHDC1 with fragment 21 (DHU_DC1_131) (2020) (0)
- Spiking burstiness and working memory in the human medial temporal lobe (2022) (0)
- 488.1-Pos Board # B29.1 – Formation of the Folding Nucleus of src-SH3 Domain from Denatured Conformations Investigated Through Biased Molecular Dynamics Simulations (2003) (0)
- Crystal structure of the human BRPF1 bromodomain in complex with BZ054 (2018) (0)
- Crystal Structure of BAZ2A bromodomain in complex with 1-methylpyridinone compound 2 (2018) (0)
- Crystal structure of UTX complexed with GSK-J1 (2018) (0)
- The ATAD2 bromodomain in complex with compound 11 (2019) (0)
- Abstract B182: The novel tyrosine kinase inhibitors UJ26 and UJ30 are active in solid tumor and hematologic cancer cell lines (2018) (0)
- Crystal structure of YTHDC1 with compound YLI_DC1_003 (2021) (0)
- Identification of a BAZ2A-Bromodomain Hit Compound by Fragment Growing (2021) (0)
- Crystal Structure of BAZ2A bromodomain in complex with 1-methylpyridinone compound 3 (2018) (0)
- Crystal structure of YTHDC1 with fragment 10 (DHU_DC1_076) (2020) (0)
- Crystal structure of YTHDC1 with compound DHU_DC1_125 (2020) (0)
- Crystal structure of the human BRPF1 bromodomain in complex with SEED9 (2016) (0)
- Crystal structure of the human METTL3-METTL14 complex with compound T30 (UZH1a) (2020) (0)
- Crystal structure of YTHDC1 with compound ADO_AC_25 (2021) (0)
- Crystal structure of the human BRPF1 bromodomain in complex with 917 (2016) (0)
- Crystal structure of hMTH1 N33G in complex with TH scaffold 1 in the absence of acetate (2019) (0)
- Crystal structure of YTHDC1 with fragment 25 (PSI_DC1_005) (2020) (0)
- Crystal Structure of BAZ2A bromodomain in complex with 1,3-dimethyl-benzimidazolone compound 1 (2017) (0)
- Crystal structure of YTHDC1 with m6A (2020) (0)
- Crystal structure of the human BRPF1 bromodomain in complex with BZ073 (2018) (0)
- MTH1 in complex with fragment 11 (2018) (0)
- Identification of BAZ2A bromodomain hit compounds (2022) (0)
- The YTH domain of YTHDC1 protein in complex with Gm6AC oligonucleotide (2019) (0)
- Monte Carlo-docking of polypeptide chains (1991) (0)
- Crystal structure of the human METTL3-METTL14 complex bound to Compound 3 (ASI_M3M_138) (2020) (0)
- Crystal structure of hMTH1 F27A in complex with TH scaffold 1 in the absence of acetate (2019) (0)
- Human EphA3 Kinase domain in complex with compound 164 (2012) (0)
- Crystal structure of the bromodomain of human CREBBP in complex with UL04 (2015) (0)
- Crystal structure of human METTL1 in complex with SAH (2021) (0)
- MTH1 in complex with fragment 4 (2018) (0)
- Crystal structure of the human BRPF1 bromodomain in complex with BZ032 (2018) (0)
- Crystal structure of the human METTL3-METTL14 complex bound to Compound 10 (ADO_AD_022) (2021) (0)
- Crystal Structure of BAZ2A bromodomain in complex with 4-propionyl-pyrrole derivative 2 (2017) (0)
- Crystal structure of the human BRPF1 bromodomain in complex with SEED11 (2016) (0)
- Crystal structure of the human BRPF1 bromodomain in complex with BZ038 (2018) (0)
- Crystal structure of YTHDC1 with compound YLI_DC1_006 (2021) (0)
- The ATAD2 bromodomain in complex with compound 17 (2019) (0)
- Evaluatio no fa Fas tImplici tSolven tMode lfo rMolecular Dynamic sSimulations (2002) (0)
- Crystal structure of the human METTL3-METTL14 complex bound to Compound 12 (ADO_AD_066) (2021) (0)
- Supporting Information for: An ABSINTH-Based Protocol for Predicting Binding Affinities Between Proteins and Small Molecules (2020) (0)
- Crystal structure of hMTH1 N33G in complex with LW14 in the absence of acetate (2019) (0)
- Crystal structure of hMTH1 in complex with TH scaffold 1 in the presence of acetate (2019) (0)
- Crystal structure of UTX complexed with 5-hydroxy-4-keto-1-methyl-picolinate (2018) (0)
- Human EphA3 Kinase domain in complex with ligand 87 (2013) (0)
- Methylations of Tryptophan Modified Naphtoquinone Affect its Inhibitory Potential towards A β Aggregation Supporting Information (2012) (0)
- Crystal Structure of BAZ2A bromodomain in complex with 3-amino-2-methylpyridine derivative 2 (2016) (0)
- Crystal structure of the human METTL3-METTL14 complex bound to Compound 9 (ADO_AD_023) (2021) (0)
- Crystal structure of computationally designed armadillo repeat proteins for modular peptide recognition. (2016) (0)
- Crystal structure of the human METTL3-METTL14 complex with compound UOZ002 (2021) (0)
- Crystal structure of the human BRPF1 bromodomain in complex with SEED6 (2016) (0)
- Crystal structure of the human METTL3-METTL14 complex bound to Compound 7 (ADO_AC_074) (2021) (0)
- Crystal structure of YTHDC1 T379V mutant complex with m6A (2021) (0)
- The ATAD2 bromodomain binds different acetylation marks on the histone H4 in similar fuzzy complexes. (2017) (0)
- Crystal structure of YTHDC1 with compound DHU_DC1_225 (2021) (0)
- Crystal structure of YTHDC1 with fragment 29 (DHU_DC1_218) (2020) (0)
- Crystal structure of YTHDC1 with compound DHU_DC1_036 (2020) (0)
- Crystal structure of YTHDC1 with compound DHU_DC1_096 (2020) (0)
- Crystal structure of YTHDC1 with fragment 7 (DHU_DC1_021) (2020) (0)
- BAZ2A bromodomain in complex with compounds MS04 and B11 (2021) (0)
- BAZ2A bromodomain in complex with triazole compound MS04-TN02 (2021) (0)
- Crystal Structure of BAZ2A bromodomain in complex with 1-methylpyridinone compound 1 (2018) (0)
- Crystal structure of hMTH1 D120N in complex with TH scaffold 1 in the absence of acetate (2019) (0)
- Crystal structure of the human BRPF1 bromodomain in complex with SEED18 (2016) (0)
- Crystal structure of YTHDC1 with compound DHU_DC1_234 (2020) (0)
- Crystal structure of the human BRPF1 bromodomain in complex with SEED12 (2016) (0)
- Crystal structure of hMTH1 F27A in complex with LW14 in the presence of acetate (2019) (0)
- Crystal structure of the human METTL3-METTL14 complex with compound UOZ016 (2021) (0)
- Crystal structure of the human BRPF1 bromodomain in complex with SEED2 (2016) (0)
- Crystal structure of the human BRPF1 bromodomain in complex with SEED1 (2016) (0)
- Crystal Structure of BAZ2A bromodomain in complex with 1-methylpyridinone compound 4 (2018) (0)
- Crystal structure of the human METTL3-METTL14 complex with compound UOZ004 (2021) (0)
- Crystal structure of YTHDC1 with compound YLI_DC1_008 (2021) (0)
- Crystal structure of CREBBP bromodomain complexd with DR09 (2018) (0)
- Crystal structure of YTHDC1 with fragment 23 (ACA_DC1_005) (2020) (0)
- Crystal structure of the human METTL3-METTL14 complex with compound UOZ038 (2021) (0)
- Crystal structure of YTHDC1 with fragment 9 (DHU_DC1_107) (2020) (0)
- Crystal structure of the human METTL3-METTL14 complex with compound UOZ113 (2021) (0)
- Crystal Structure of BAZ2B bromodomain in complex with N-methyltrimethylacetamide (2016) (0)
- Crystal structure of YTHDC1 with fragment 18 (DHU_DC1_048) (2020) (0)
- Crystal structure of YTHDC1 with compound PSI_DC1_004 (2021) (0)
- The ATAD2 bromodomain in complex with compound 7 (2019) (0)
- Crystal structure of the human METTL3-METTL14 complex with compound UOZ031 (2021) (0)
- Crystal structure of YTHDC1 with compound DHU_DC1_092 (2020) (0)
- Human EphA3 Kinase domain in complex with quinoxaline derivatives (2014) (0)
- Crystal structure of hMTH1 D120N in complex with LW14 in the presence of acetate (2019) (0)
- Crystal structure of UTX complexed with 5-carboxy-8-hydroxyquinoline (2018) (0)
- X-Ray Diffraction data from Human EphA3 Kinase domain in complex with Birb796, source of 4TWN structure (2015) (0)
- X-Ray Diffraction data from BAZ2B bromodomain in complex with fragment F103, source of 5E9L structure (2016) (0)
- Fragment-Based High Throughput Docking (2005) (0)
- Crystal structure of YTHDC1 with compound DHU_DC1_046 (2020) (0)
- Crystal structure of the human BRPF1 bromodomain in complex with BZ135 (2018) (0)
- Crystal structure of the bromodomain of human CREBBP in complex with UO37D (2017) (0)
- Crystal Structure of BAZ2A bromodomain in complex with 4-chloropyridine derivative 3 (2017) (0)
- Crystal structure of the human METTL3-METTL14 complex bound to Compound 21 (ADO_AD_089) (2021) (0)
- Crystal structure of YTHDC1 with fragment 4 (DHU_DC1_158) (2020) (0)
- Crystal structure of the human METTL3-METTL14 complex bound to Sinefungin (2020) (0)
- Supporting Information for : Weighted distance functions improve analysis of high-dimensional data : application to molecular dynamics simulations (2015) (0)
- Crystal structure of the human METTL3-METTL14 complex with compound T180 (0)
- Structural insights into amyloid-β(1-42) fibril elongation (2018) (0)
- Crystal structure of YTHDC1 with fragment 6 (DHU_DC1_034) (2020) (0)
- Crystal structure of YTHDC1 with compound T_96 (2020) (0)
- K. O. Emery & E. Uchupi 1984. The Geology of the Atlantic Ocean. Two volumes, xx + 1050 pp. + 23 oversize folded charts. Berlin, Heidelberg, New York, Tokyo: Springer-Verlag. Price DM 369.00 ISBN 3 540 96032 5. (1986) (0)
- Crystal structure of the human BRPF1 bromodomain in complex with BZ089 (2018) (0)
- Crystal structure of YTHDC1 with fragment 12 (DHU_DC1_150) (2020) (0)
- Crystal structure of YTHDC1 with fragment 8 (DHU_DC1_006) (2020) (0)
- Crystal structure of the human METTL3-METTL14 complex bound to Compound 5 (ASI_M3M_051) (2020) (0)
- Crystal structure of YTHDF3 YTH domain in complex with m6A RNA (2020) (0)
- Crystal structure of YTHDC1 with compound YLI_DC1_001 (2021) (0)
- Proteomic analyses identify ARH3 as a serine mono-ADP-ribosylhydrolase (2017) (0)
- Crystal Structure of the first bromodomain of human BRD4 in complex with compound B13 (2014) (0)
- Crystal structure of the human METTL3-METTL14 complex bound to Compound 17 (ADO_AE_005) (2021) (0)
- Crystal structure of YTHDC1 T379V mutant (2021) (0)
- The ATAD2 bromodomain in complex with compound 15 (2019) (0)
- Crystal structure of YTHDC1 with compound DHU_DC1_068 (2020) (0)
- Crystal structure of the human METTL3-METTL14 complex bound to Compound 15 (ADO_AE_026) (2021) (0)
- Crystal structure of hMTH1 N33G in complex with TH scaffold 1 in the presence of acetate (2019) (0)
- Unsupervised Methods for Detection of Neural States: Case Study of Hippocampal-Amygdala Interactions (2021) (0)
- Crystal structure of the human METTL3-METTL14 complex with compound UOZ019b (2021) (0)
- Crystal structure of YTHDC1 with fragment 15 (DHU_DC1_169) (2020) (0)
- Crystal structure of YTHDC1 with compound DHU_DC1_139 (2020) (0)
- Crystal structure of the human METTL3-METTL14 complex with compound UOZ091 (2021) (0)
- Structure of CREBBP bromodomain with compound 2 bound (2020) (0)
- Crystal structure of CREBBP bromodomain complexed with LA36 (2020) (0)
- Crystal Structure of BAZ2B bromodomain in complex with 1-methyl-cyclopentapyrazole compound 30 (2017) (0)
- Crystal structure of YTHDC1 with fragment 3 (DHU_DC1_149) (2020) (0)
- Crystal structure of YTHDC1 with compound DHU_DC1_085 (2020) (0)
- Crystal Structure of BAZ2B bromodomain in complex with fragment F60 (2016) (0)
- Crystal structure of the human METTL3-METTL14 complex with compound UOZ120 (2021) (0)
- The ATAD2 bromodomain in complex with compound 12 (2018) (0)
- Crystal structure of the human BRPF1 bromodomain in complex with BZ097 (2018) (0)
- Crystal structure of CREBBP bromodomain L1109W mutant (2019) (0)
- Crystal structure of YTHDC1 with fragment 14 (ACA_DC1_004) (2020) (0)
- Crystal structure of the human METTL3-METTL14 complex bound to Compound 20 (ADO_AD_044) (2021) (0)
- Crystal structure of YTHDC1 with compound YLI_DC1_002 (2021) (0)
- Crystal structure of YTHDC1 with compound DHU_DC1_226 (2021) (0)
- Crystal structure of the human METTL3-METTL14 complex with compound DHU_M3M_154 (2021) (0)
- Crystal Structure of BAZ2B bromodomain in complex with fragment F59 (2016) (0)
- HADDOCK calculated model of LIN5001 bound to the HET-s amyloid (2017) (0)
- Crystal structure of YTHDC1 with fragment 11 (DHU_DC1_128) (2020) (0)
- Crystal structure of human BRD4(1) bromodomain in complex with DR46 (2018) (0)
- Crystal structure of YTHDC1 M438A mutant complex with m6A (2021) (0)
- Crystal structure of YTHDC1 with compound VVR_DC1_002 (2020) (0)
- Crystal structure of the human BRPF1 bromodomain in complex with SEED17 (2016) (0)
- Crystal structure of YTHDC1 with fragment 16 (DHU_DC1_017) (2020) (0)
- Crystal structure of the human BRPF1 bromodomain in complex with BZ053 (2018) (0)
- Crystal structure of the human METTL3-METTL14 complex bound to Compound 13 (ADO_AD_091) (2021) (0)
- Crystal structure of the human BRPF1 bromodomain in complex with SEED16 (2016) (0)
- PAGE: An efficient and reliable software to predict protein aggregation (2005) (0)
- Crystal structure of YTHDC1 with fragment 1 (DHU_DC1_141) (2020) (0)
- Crystal Structure of BAZ2B bromodomain in complex with 1-methylpyridinone compound 2 (2018) (0)
- The YTH domain of YTHDC1 protein in complex with GGm6AC oligonucleotide (2019) (0)
- Crystal structure of YTHDC1 with compound T96 (2021) (0)
- Crystal structure of the human BRPF1 bromodomain in complex with SEED13 (2016) (0)
- Crystal structure of YTHDC1 with compound ADO_AC_89 (2021) (0)
- The YTH domain of YTHDC1 protein in complex with Gm6ACU oligonucleotide (2019) (0)
- Crystal structure of the human BRPF1 bromodomain in complex with Bromosporine (2015) (0)
- Sapphire-based clustering Supporting information (2020) (0)
- The ATAD2 bromodomain in complex with compound 2 (2018) (0)
- Supporting Information The 3 A 6-TCR / superagonist / HLA-DR 2 a complex shows similar interface and reduced flexibility compared to the complex with self-peptide (2019) (0)
- Crystal Structure of BAZ2B bromodomain in complex with 1-methyl-cyclopentapyrazole compound 13 (2017) (0)
- The TCR/peptide/MHC complex with a superagonist peptide shows similar interface and reduced flexibility compared to the complex with a self-peptide (2019) (0)
- Crystal structure of the human BRPF1 bromodomain in complex with XZ08 (2016) (0)
- Crystal structure of CREBBP bromodomain complexed with KD341 (2020) (0)
- Crystal structure of the human BRPF1 bromodomain in complex with SEED14 (2016) (0)
- Crystal structure of the human BRPF1 bromodomain in complex with BZ091 (2018) (0)
- Crystal structure of the human BRPF1 bromodomain in complex with SEED5 (2016) (0)
- Discovery of BAZ2A Bromodomain Ligands (2017) (0)
- Crystal structure of the human METTL3-METTL14 complex with compound UOZ097 (2021) (0)
- Crystal structure of the human METTL3-METTL14 complex with compound UOZ058 (2021) (0)
- Crystal structure of YTHDC1 with fragment 27 (DHU_DC1_256) (2020) (0)
- Crystal structure of the bromodomain of human CREBBP in complex with AYC (2016) (0)
- P. H. Nixon (ed.) 1987. Mantle Xenoliths. xviii + 844 pp. Chichester, New York, Brisbane, Toronto, Singapore: John Wiley. Price £99.00 (hard covers). ISBN 0 471 91209 3. (1988) (0)
- The ATAD2 bromodomain in complex with compound 8 (2019) (0)
- Crystal structure of the human BRPF1 bromodomain in complex with SEED4 (2016) (0)
- Crystal structure of hMTH1 F27A in complex with TH scaffold 1 in the presence of acetate (2019) (0)
- Crystal structure of human BRD4(1) bromodomain in complex with UT48 (2018) (0)
- Crystal structure of the human BRPF1 bromodomain in complex with SEED20 (2016) (0)
- The ATAD2 bromodomain in complex with compound UZH-DU32 (2018) (0)
- X-Ray Diffraction data from BAZ2B bromodomain in complex with acetylindole compound UZH47, source of 5E73 structure (2016) (0)
- Crystal Structure of BAZ2B bromodomain in complex with fragment F275 (2016) (0)
- Crystal structure of the human BRPF1 bromodomain in complex with SEED8 (2016) (0)
- Crystal structure of hMTH1 F27A in the presence of acetate (2019) (0)
- The 3A6‐TCR/superagonist/HLA‐DR2a complex shows similar interface and reduced flexibility compared to the complex with self‐peptide (2019) (0)
- Crystal structure of the human BRPF1 bromodomain complexed with BZ054 in space group C2 (2018) (0)
- The ATAD2 bromodomain in complex with compound 16 (2019) (0)
- The role of the first transmembrane helix in bacterial YidC: Insights from the crystal structure and molecular dynamics simulations (2021) (0)
- Crystal structure of hMTH1 F27A in complex with LW14 in the absence of acetate (2019) (0)
- Crystal structure of the human METTL3-METTL14 complex with compound ASI_M3M_041 (2021) (0)
- Crystal Structure of BAZ2B bromodomain in complex with 1-methylpyridinone compound 4 (2018) (0)
- Formation of the folding nucleus of src-SH3 domain from denatured conformations investigated through biased molecular dynamics simulations (2003) (0)
- Crystal structure of YTHDC1 with compound DHU_DC1_011 (2020) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Amedeo Caflisch?
Amedeo Caflisch is affiliated with the following schools:
